Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2022

Nov 2, 2022

30150_dirs_2022-11-02_3fad3637-ad55-4c77-996c-8d22cfd4a667.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-10-31

Reporting Person: SHAROKY MELVIN MD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-10-31 Common Stock P 20000 $17.53 Acquired 281021 Direct
2022-11-01 Common Stock P 10000 $17.70 Acquired 15900 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1847 Indirect
Common Stock 1184 Indirect
Common Stock 1600 Indirect

Footnotes

F1: This is the weighted average purchase price representing the shares purchased at prices ranging from $17.32 to $17.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

F2: This is the weighted average purchase price representing the shares purchased at prices ranging from $17.68 to $17.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

F3: The Reporting Person is a managing member of Baby Gator LLC.

F4: The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

F5: The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.